English | Español

American Academy Of Neurology
+ Technology/Innovation
Sam Jackson | Apr 25, 2023

Teriflunomide study shows promise in delaying first symptoms of MS using medication as an 'early intervention'
+ Technology/Innovation
Sam Jackson | Apr 25, 2023

New drug shows promise in preventing migraines for patients unresponsive to other treatments: 'These results are exciting'

+ Technology/Innovation
Press release submission | May 2, 2019

AMERICAN ACADEMY OF NEUROLOGY: Cannabis-based Medicine May Reduce Seizures for Children with Difficult-to-Treat Epilepsy
+ Regulatory
Robert Hadley | May 16, 2017

Immunosuppressive drug cladribine may slow progression of MS
+ Technology/Innovation
Ruth de Jauregui | May 7, 2017

Data from multiple sclerosis medication study shows promise
+ Technology/Innovation
Robert Hadley | May 3, 2017

Clinical trial results offer hope for multiple sclerosis sufferers
+ Technology/Innovation
Amanda Rupp | May 22, 2016

New ALS research announced at annual conference
+ Community
Amanda Rupp | Apr 21, 2016

ALS Association announces new research fellowships

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes